– Reuters Citing Conf Call
Sage Therapeutics/Biogen Highlight Additional Data From Depression Candidate
Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc (NASDAQ:BIIB) presented additional data from the Phase 3 SKYLARK Study of zuranolone in adult women with…